C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
1.250
-0.070 (-5.30%)
May 30, 2025, 4:00 PM - Market closed
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $88.76 million as of May 30, 2025. Its market cap has decreased by -79.09% in one year.
Market Cap
88.76M
Enterprise Value
-83.36M
1-Year Change
-79.09%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $88.76M, a decrease of -88.51%. That is a compound annual growth rate of -37.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 93.73M | -63.12% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.82B |
| Johnson & Johnson | 366.76B |
| AbbVie | 323.41B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.43B |
| Abbott Laboratories | 229.69B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |